| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Impact of the Human Genome on Endocrinology: Original Articles |
Medical Research Council Human Reproductive Sciences Unit (P.T.K.S., M.R.M., S.M., D.S.I., R.M.S., G.A.S.), Centre for Reproductive Biology, Edinburgh EH3 9ET, United Kingdom; and School of Biological & Molecular Sciences (N.P.G., L.R.E.), Oxford Brookes University, Gypsy Lane Campus, Headington, Oxford OX3 0PB, United Kingdom
Address all correspondence and requests for reprints to: Dr. Philippa T. K. Saunders, Medical Research Council Human Reproductive Sciences Unit, Center for Reproductive Biology, 37 Chalmers Street, Edinburgh EH3 9ET, United Kingdom. E-mail: . p.saunders{at}ed.ac.uk
Abstract
Estrogens can regulate germ cell function. Estrogen action is mediated via high affinity ERs; two subtypes (ER
and ERß) have been identified. We have shown previously that ERß is expressed in nuclei of multiple human testicular cells. A variant isoform of human (h) ERß (hERßcx/2), formed by alternative splicing, has been identified in testicular cDNA libraries by two laboratories. The present study examined the expression of wild-type (ERß1) and variant (ERß2) ß receptors in human testes by 1) RT-PCR with isoform specific primers, and 2) single and double immunohistochemistry using monoclonal antibodies raised against peptides unique to the C termini of hERß1 and hERß2. PCR products specific for ERß1 and ERß2 were amplified from cDNA pools prepared from human testes and granulosa cells. On Western blots, the anti-ERß1 monoclonal antibody bound to recombinant ERß1 and the anti-ERß2 monoclonal to recombinant hERß2. Neither bound to the other ERß isoform nor to recombinant ER
. ERß1 and ERß2 proteins were both detected in human testis. Immunoexpression of ERß1 was most intense in pachytene spermatocytes and round spermatids, whereas low levels of expression were detected in Sertoli cells, spermatogonia, preleptotene, leptotene, zygotene, and diplotene spermatocytes. Highest levels of expression of ERß2 protein were detected in Sertoli cells and spermatogonia with low/variable expression in preleptotene, pachytene, and diplotene spermatocytes. No immunostaining was detected in elongating spermatids. Most interstitial cells expressed more ERß2 than ERß1. It is speculated that the cells most susceptible to modulation by estrogenic ligands are round spermatids in which levels of expression of ERß1 are high. In contrast, expression of ERß2, an isoform that may act as a dominant negative inhibitor of ER action, in Sertoli cells and spermatogonia, could protect these cells from adverse effects of estrogens.
This article has been cited by other articles:
![]() |
N Gatt, J Attard, and J Degaetano Adenofibroma of the testis J. Clin. Pathol., June 1, 2009; 62(6): 558 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Rakha, S. E. Elsheikh, M. A. Aleskandarany, H. O. Habashi, A. R. Green, D. G. Powe, M. E. El-Sayed, A. Benhasouna, J.-S. Brunet, L. A. Akslen, et al. Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes Clin. Cancer Res., April 1, 2009; 15(7): 2302 - 2310. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Han, H. L. Feng, J. I. Sandlow, and C. J. Haines Comparing Expression of Progesterone and Estrogen Receptors in Testicular Tissue From Men With Obstructive and Nonobstructive Azoospermia J Androl, March 1, 2009; 30(2): 127 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Shaaban, A. R. Green, S. Karthik, Y. Alizadeh, T. A. Hughes, L. Harkins, I. O. Ellis, J. F. Robertson, E. C. Paish, P. T.K. Saunders, et al. Nuclear and Cytoplasmic Expression of ER{beta}1, ER{beta}2, and ER{beta}5 Identifies Distinct Prognostic Outcome for Breast Cancer Patients Clin. Cancer Res., August 15, 2008; 14(16): 5228 - 5235. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F.G Lucas, E. R Siu, C. A Esteves, H. P Monteiro, C. A Oliveira, C. S Porto, and M. F. M Lazari 17Beta-Estradiol Induces the Translocation of the Estrogen Receptors ESR1 and ESR2 to the Cell Membrane, MAPK3/1 Phosphorylation and Proliferation of Cultured Immature Rat Sertoli Cells Biol Reprod, January 1, 2008; 78(1): 101 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Carpino, V. Rago, V. Pezzi, C. Carani, and S. Ando Detection of aromatase and estrogen receptors (ER{alpha}, ER{beta}1, ER{beta}2) in human Leydig cell tumor Eur. J. Endocrinol., August 1, 2007; 157(2): 239 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Sneddon, N. Walther, and P. T. K. Saunders Expression of Androgen and Estrogen Receptors in Sertoli Cells: Studies Using the Mouse SK11 Cell Line Endocrinology, December 1, 2005; 146(12): 5304 - 5312. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Modi, C Shah, G Sachdeva, S Gadkar, D Bhartiya, and C Puri Ontogeny and cellular localization of SRY transcripts in the human testes and its detection in spermatozoa Reproduction, November 1, 2005; 130(5): 603 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Roger, S Lambard, A Bouskine, B Mograbi, D Chevallier, M Nebout, G Pointis, S Carreau, and P Fenichel Estrogen-induced growth inhibition of human seminoma cells expressing estrogen receptor {beta} and aromatase J. Mol. Endocrinol., August 1, 2005; 35(1): 191 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Shah, D. Modi, G. Sachdeva, S. Gadkar, and C. Puri Coexistence of Intracellular and Membrane-Bound Progesterone Receptors in Human Testis J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 474 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
M P A Davies, P A O'Neill, H Innes, D R Sibson, W Prime, C Holcombe, and C S Foster Correlation of mRNA for oestrogen receptor beta splice variants ER{beta}1, ER{beta}2/ER{beta}cx and ER{beta}5 with outcome in endocrine-treated breast cancer J. Mol. Endocrinol., December 1, 2004; 33(3): 773 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pais, I. Leav, K.-M. Lau, Z. Jiang, and S.-M. Ho Estrogen Receptor-{beta} Expression in Human Testicular Germ Cell Tumors Clin. Cancer Res., October 1, 2003; 9(12): 4475 - 4482. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Brown, G. A. Scobie, J. Townsend, R. A. L. Bayne, J. R. Seckl, P. T. K. Saunders, and R. A. Anderson Identification of a Novel Missense Mutation That Is as Damaging to DAX-1 Repressor Function as a Nonsense Mutation J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1341 - 1349. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nair and C. Shaha Diethylstilbestrol Induces Rat Spermatogenic Cell Apoptosis in Vivo through Increased Expression of Spermatogenic Cell Fas/FasL System J. Biol. Chem., February 14, 2003; 278(8): 6470 - 6481. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Gaskell, L. L. L. Robinson, N. P. Groome, R. A. Anderson, and P. T. K. Saunders Differential Expression of Two Estrogen Receptor {beta} Isoforms in the Human Fetal Testis during the Second Trimester of Pregnancy J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 424 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Henderson, P. T. K. Saunders, A. Moffett-King, N. P. Groome, and H. O. D. Critchley Steroid Receptor Expression in Uterine Natural Killer Cells J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 440 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Anderson and D. T. Baird Male Contraception Endocr. Rev., December 1, 2002; 23(6): 735 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. O. D. Critchley, T. A. Henderson, R. W. Kelly, G. S. Scobie, L. R. Evans, N. P. Groome, and P. T. K. Saunders Wild-Type Estrogen Receptor (ER{beta}1) and the Splice Variant (ER{beta}cx/{beta}2) Are Both Expressed within the Human Endometrium throughout the Normal Menstrual Cycle J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5265 - 5273. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |